Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Adamec

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Croatian Medical Journal|November 5, 2020
The incidence of postural orthostatic tachycardia syndrome in the population of Zagreb, CroatiaIvan Adamec, Luka Crnošija, Berislav Ruška, et al.
Acta Neurologica Belgica|June 1, 2023
COVID-19 vaccination uptake in people with multiple sclerosis compared to the general populationDijana Mayer, Barbara Barun, Karla Lazibat, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|December 5, 2025
Characterizing sweating problems in multiple sclerosis: insights from QSART, SUDOSCAN, and COMPASS-31: Sweating Problems in Multiple SclerosisKaty Jerčinović, Katarina Tešija, Mašan Sredanović, et al.
Multiple Sclerosis and Related Disorders|July 13, 2020
Acute pancreatitis after ocrelizumab treatment for relapsing remitting multiple sclerosisIvan Adamec, Željko Reiner, Ivan Pećin, et al.
Autonomic Neuroscience : Basic & Clinical|December 19, 2012
Postural orthostatic tachycardia syndrome associated with multiple sclerosisIvan Adamec, Mila Lovrić, Dinka Žaper, et al.
Multiple Sclerosis and Related Disorders|December 28, 2020
Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectivenessBarbara Barun, Tereza Gabelić, Ivan Adamec, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|July 30, 2022
Blood pressure variability is altered in secondary progressive multiple sclerosis but not in patients with a clinically isolated syndromeLuka Crnošija, Ivan Moštak, Nika Višnjić, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 24, 2025
Evolution of autonomic nervous system abnormalities in multiple sclerosis: a 6-year follow-upBerislav Ruška, Ivan Adamec, Luka Crnosija, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 25, 2018
Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life settingBerislav Ruška, Tin Pavičić, Ivan Pavlović, et al.
Multiple Sclerosis and Related Disorders|July 7, 2026
Immunoglobulin dynamics and infection risk with ofatumumab versus ocrelizumab in multiple sclerosisKatarina Tešija, Mašan Sredanović, Laura Zanetti, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Croatian Medical Journal|November 5, 2020
The incidence of postural orthostatic tachycardia syndrome in the population of Zagreb, CroatiaIvan Adamec, Luka Crnošija, Berislav Ruška, et al.
Acta Neurologica Belgica|June 1, 2023
COVID-19 vaccination uptake in people with multiple sclerosis compared to the general populationDijana Mayer, Barbara Barun, Karla Lazibat, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|December 5, 2025
Characterizing sweating problems in multiple sclerosis: insights from QSART, SUDOSCAN, and COMPASS-31: Sweating Problems in Multiple SclerosisKaty Jerčinović, Katarina Tešija, Mašan Sredanović, et al.
Multiple Sclerosis and Related Disorders|July 13, 2020
Acute pancreatitis after ocrelizumab treatment for relapsing remitting multiple sclerosisIvan Adamec, Željko Reiner, Ivan Pećin, et al.
Autonomic Neuroscience : Basic & Clinical|December 19, 2012
Postural orthostatic tachycardia syndrome associated with multiple sclerosisIvan Adamec, Mila Lovrić, Dinka Žaper, et al.
Multiple Sclerosis and Related Disorders|December 28, 2020
Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectivenessBarbara Barun, Tereza Gabelić, Ivan Adamec, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|July 30, 2022
Blood pressure variability is altered in secondary progressive multiple sclerosis but not in patients with a clinically isolated syndromeLuka Crnošija, Ivan Moštak, Nika Višnjić, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 24, 2025
Evolution of autonomic nervous system abnormalities in multiple sclerosis: a 6-year follow-upBerislav Ruška, Ivan Adamec, Luka Crnosija, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 25, 2018
Performance of the COMPASS-31 questionnaire with regard to autonomic nervous system testing results and medication use: a prospective study in a real-life settingBerislav Ruška, Tin Pavičić, Ivan Pavlović, et al.
Multiple Sclerosis and Related Disorders|July 7, 2026
Immunoglobulin dynamics and infection risk with ofatumumab versus ocrelizumab in multiple sclerosisKatarina Tešija, Mašan Sredanović, Laura Zanetti, et al.
Pageof 14